Rupert Timpl Selected Research

Therapeutics

1/2002

Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rupert Timpl Research Topics

Disease

5	Neoplasms (Cancer) 12/2004 - 01/2002
1	Experimental Sarcoma 07/2010
1	Liver Diseases (Liver Disease) 09/2009
1	type 2 alpha 1 Collagenopathy 11/2006
1	Epidermolysis Bullosa 10/2003
1	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 10/2003
1	Cutis Laxa 04/2003
1	recessive Cutis laxa 04/2003
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 07/2002
1	Adenoid Cystic Carcinoma (Cylindroma) 02/2002
1	Glioma (Gliomas) 01/2002
1	Hypertrophy 01/2002
1	Brain Neoplasms (Brain Tumor) 01/2002
1	Vascular Tissue Neoplasms 01/2002
1	Gliosarcoma 01/2002

Drug/Important Bio-Agent (IBA)

4	EndostatinsIBA 12/2004 - 01/2002
2	Laminin (Merosin)IBA 07/2010 - 10/2003
2	Proteins (Proteins, Gene)FDA Link 09/2009 - 01/2002
2	Peptides (Polypeptides)IBA 12/2004 - 10/2003
2	KalininIBA 10/2003 - 02/2002
1	perlecanIBA 11/2006
1	Heparin (Liquaemin)FDA LinkGeneric 12/2004
1	Amino Acids FDA Link 12/2004
1	ElastinIBA 04/2003
1	ProcollagenIBA 07/2002
1	IntegrinsIBA 02/2002
1	Integrin alpha6beta4IBA 02/2002
1	laminin 10IBA 02/2002
1	Aggrecans (Aggrecan)IBA 01/2002
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2002
1	AntibodiesIBA 01/2002
1	Alcian BlueIBA 01/2002
1	Collagen Type II (Type II Collagen)IBA 01/2002
1	Collagen Type XIBA 01/2002
1	Collagen Type XVIII (Type XVIII Collagen)IBA 01/2002

Therapy/Procedure

1	Therapeutics 01/2002